StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
HKPDCellyan Biotechnology Co., Ltd
stockpulse.co.kr
Nasdaq
$0.1020▲ 1.19%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $2.4MShares out 23.5M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

6
  • 3d agoPre-market26.10.21 21:00
    6-KKey event#●●●#●●●

    Cellyan Biotechnology Co., Ltd

    Cellyan Biotechnology will implement a 1-for-20 reverse stock split effective October 26, 2026, to regain compliance with Nasdaq's minimum bid price requirement. Following the consolidation, every 20 outstanding shares will be combined into one, and the par value will increase from $0.001 to $0.02 per share.…more

    $0.1020+1.19%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.24Pre-market26.09.24 10:20filed
    6-KKey event

    Cellyan Biotechnology Co., Ltd

    Cellyan Biotechnology Co., Ltd announced the resignation of independent director Mike Yao Zhou, effective September 18, 2026. On the same day, the company appointed Letao Zhao as his successor, who will serve as an independent director and chair the Compensation Committee.…more

    $0.1020+1.19%vs prev close
    View filingShare
  • 9.23Pre-market26.09.23 22:10
    6-KKey event

    Cellyan Biotechnology Co., Ltd

    Cellyan Biotechnology Co., Ltd. held an extraordinary general meeting of shareholders on September 21, 2026, and approved a 1-for-20 share consolidation. This action will change the par value of the company's ordinary shares from $0.001 to $0.02 and includes the adoption of amended and restated articles of association.…more

    $0.1020+1.19%vs prev close
    View filingShare

5 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 3d agoPre-market26.10.21 21:01
    Bullish#●●●

    Cellyan Biotechnology Announces 1-For-20 Reverse Stock Split

    Cellyan Biotechnology has announced a 1-for-20 reverse stock split effective October 26. This corporate action is typically implemented to increase share price or maintain exchange listing compliance.…more

    $0.1020+1.19%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga